Approval · Notice of Compliance 11545 · 2010
AZASITE: Notice of Compliance 11545
Issued June 21, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11545
- Date
- June 21, 2010
- Company
- Inspire Pharmaceuticals IncLake Forest, Illinois, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Macrolide antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AZASITE | 02345498 | Cancelled Pre Market |
Medicinal ingredients
- AZITHROMYCIN 1 PER